15-44668982-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001387263.1(PATL2):c.1222C>A(p.Gln408Lys) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.00000072 in 1,388,466 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001387263.1 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PATL2 | NM_001387263.1 | c.1222C>A | p.Gln408Lys | missense_variant, splice_region_variant | Exon 14 of 18 | ENST00000682850.1 | NP_001374192.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PATL2 | ENST00000682850.1 | c.1222C>A | p.Gln408Lys | missense_variant, splice_region_variant | Exon 14 of 18 | NM_001387263.1 | ENSP00000508024.1 | |||
PATL2 | ENST00000434130.6 | c.1222C>A | p.Gln408Lys | missense_variant, splice_region_variant | Exon 12 of 16 | 5 | ENSP00000416673.1 | |||
PATL2 | ENST00000560780.1 | c.655C>A | p.Gln219Lys | missense_variant, splice_region_variant | Exon 11 of 15 | 2 | ENSP00000453695.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 7.20e-7 AC: 1AN: 1388466Hom.: 0 Cov.: 32 AF XY: 0.00000146 AC XY: 1AN XY: 683608
GnomAD4 genome Cov.: 32
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.